In addition, adiponectin concentration, oxidative stress, and endothelial dysfunction in NAFLD patients also contribute to the development of atherosclerosis (2, 59–61). This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.